Podcast: Alopecia Areata in Conversation
Clinical conversations in alopecia areata
How can we ensure our patients with alopecia areata (AA) receive the best possible care as new treatment options and assessment tools emerge? Hear from leading experts as they share clinical insights and forward-thinking strategies for implementing patient-centric care.
Stay tuned to this podcast series for more expert discussions focused on improving patient outcomes.
The growing role of JAK inhibitors in alopecia areata
Episode 3. “We now have great treatments – but patients need to give them time.” Luiza Kalil and Mark Lebwohl discuss how JAK inhibitors are transforming care for patients with AA, from expanding treatment options to shifting patient expectations. They explore practical strategies for choosing systemic therapies, navigating black box warnings, and setting patient expectations around timelines and responses.
“Time is hair”: AA diagnosis across populations
Episode 2. Brittany Craiglow and Amy McMichael examine the complexities of diagnosing AA across different racial and ethnic groups. They discuss how clinical and trichoscopic features can vary, especially in patients of color, and the implications for diagnosis and treatment. They also cover common misdiagnoses, the role of SALT scoring, best practices for biopsy technique, and the importance of photo documentation in tracking patient progress.
Evolving assessment and treatment strategies
Episode 1. “It’s really, really fun to see people grow hair.” Brittany Craiglow welcomes Luiza Kalil to explore evolving strategies for assessing and treating AA, including severity scoring tools, nuanced decisions around systemic therapies, and the pivotal role of shared decision-making in tailoring treatment to individual patient needs.
Developed by EPG Health. This content has been developed independently of the sponsor, Pfizer, which has reviewed the content only for scientific accuracy. EPG Health received funding from the sponsor in order to help provide healthcare professionals with access to the highest quality medical and scientific information, education and associated relevant content.